title: Anesthetic implications of the new anticoagulant and antiplatelet drugs.
abstract: In this review, we discuss the anesthetic implications of the new anticoagulant and antiplatelet drugs, focusing our discussion mainly on neuroaxial/regional anesthesia and central catheter placement issues. We offer practical recommendations for their use.
authors.affiliation: Department of Anesthesiology, University of Washington, Campus PO Box 356540, 1959 NE Pacific Street, Seattle, WA 98195-6540, USA.
authors.forename: Alexander A
authors.initials: AA
authors.lastname: Vitin
authors.forename: Gregory
authors.initials: G
authors.lastname: Dembo
authors.forename: Youri
authors.initials: Y
authors.lastname: Vater
authors.forename: Kenneth
authors.initials: K
authors.lastname: Martay
authors.forename: Leonard
authors.initials: L
authors.lastname: Azamfirei
authors.forename: Tiberiu
authors.initials: T
authors.lastname: Ezri
mesh_terms: D000758:Anesthesia; D000818:Animals; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D000990:Antithrombin III / Q000502:physiology; D065427:Factor Xa Inhibitors; D005340:Fibrinogen / Q000037:antagonists & inhibitors; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D013917:Thrombin / Q000037:antagonists & inhibitors
chemical_list: D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D010975:Platelet Aggregation Inhibitors; D000990:Antithrombin III; D005340:Fibrinogen; D006493:Heparin; D013917:Thrombin